The expression of SLAMF7 levels in malignant B cells: a novel therapeutic pathway for patients with CLL. Journal of Science and Technology, [S. l.], v. 35, n. 1, 2016. DOI: 10.4314/just.v35i1.349. Disponível em: https://journal.knust.edu.gh/index.php/just/article/view/349. Acesso em: 11 jun. 2026.